The 2026 Compounded Peptide Policy Shift: What Returning Category‑1 Peptides Mean for Research Access
Roughly 14 peptides moved from a restricted regulatory category to a legally compoundable one in early 2026 — a shift that reversed years of restricted access for researchers, clinicians, and patients alike. T…
Read guide →